Try it
Pharmacology · Parkinsonism: vitamin B6 and levodopa
Sample itemA patient receiving levodopa alone takes a multivitamin containing pyridoxine and his symptom control worsens. What explains this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Pyridoxine is a cofactor that enhances peripheral dopa decarboxylase, converting levodopa to dopamine outside the brain
Vitamin B6 is a cofactor of dopa decarboxylase, so in the absence of carbidopa more levodopa is decarboxylated peripherally and less reaches the brain. Carbidopa avoids this problem, so the interaction is not seen with levodopa-carbidopa.
Option by option
A. Pyridoxine inhibits COMT
COMT inhibition would increase levodopa effect.
B. Pyridoxine is a cofactor that enhances peripheral dopa decarboxylase, converting levodopa to dopamine outside the brain (correct)
Correct. Peripheral decarboxylation reduces central levodopa.
C. Pyridoxine inhibits levodopa absorption by chelation
Chelation is not the mechanism.
D. Pyridoxine blocks dopamine receptors
Pyridoxine does not block dopamine receptors.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?